A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study

A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study

Background: Despite the increasing use of biologics in severe asthma, there is limited research on their use in asthma-chronic obstructive pulmonary disease overlap (ACO). We compared real-world treatment responses to biologics in ACO and asthma. Methods: We conducted a multicenter, retrospective, c...

Full description

Bibliographic Details
Main Authors: Ji-Su Shim, MD, PhD, Hyunkyoung Kim, MS, Jae-Woo Kwon, MD, PhD, So-Young Park, MD, PhD, Sujeong Kim, MD, PhD, Byung-Keun Kim, MD, PhD, Young-Hee Nam, MD, PhD, Min-Suk Yang, MD, PhD, Mi-Yeong Kim, MD, PhD, Sae-Hoon Kim, MD, PhD, Byung-Jae Lee, MD, PhD, Taehoon Lee, MD, PhD, Sang-Ha Kim, MD, PhD, So Young Park, MD, PhD, Young-Joo Cho, MD, PhD, Chan Sun Park, MD, PhD, Jae-Woo Jung, MD, PhD, Han-Ki Park, MD, PhD, Joo-Hee Kim, MD, PhD, Jeong-Hee Choi, MD, PhD, Ji-Yong Moon, MD, PhD, Ian Adcock, MD, PhD, Kian Fan Chung, MD, PhD, Min-Hye Kim, MD, PhD, Tae-Bum Kim, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:World Allergy Organization Journal
Subjects:
Asthma-COPD overlap
Asthma
Biologics
Monoclonal antibodies
Treatment response
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123001084

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123001084

Similar Items